AATMAJ vs FISCHER: Stock Comparison

AATMAJ vs FISCHER MEDICAL VENTURE LUpdated 21 Sept 26, 4:08 PM ISTNSE & company filings

FISCHER MEDICAL VENTURE L is the larger company by market capitalisation. AATMAJ shows a higher ROE and a higher ROCE, while FISCHER MEDICAL VENTURE L shows a higher dividend yield, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AATMAJ leads 3; FISCHER leads 7 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AATMAJFISCHER

Valuation lens

What price are you paying?

Market CapContext only
₹44 Cr
₹2,160 Cr
P/E RatioSame reading
72.72x
P/B RatioSame reading
5.7x
EPSFISCHER has the higher reading
₹0.32
₹0.45
Book ValueContext only
₹22.49
₹5.96
Dividend YieldFISCHER has the higher reading
0%
0.15%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
FISCHER is the larger company
₹2,160 Cr vs ₹44 Cr
EPS
FISCHER has higher earnings per share
₹0.45 vs ₹0.32
Dividend Yield
FISCHER has a higher dividend yield
0.15% vs 0%
Revenue Growth (TTM YoY)
FISCHER has faster revenue growth
98.7% vs 0%
Qtr Sales Growth
FISCHER has stronger quarterly sales growth
11,250.98% vs 124.95%
Qtr Profit Growth
FISCHER has stronger quarterly profit growth
208.2% vs 39.69%
ROE
AATMAJ has a higher ROE
1.4% vs -3.08%
ROCE
AATMAJ has a higher ROCE
2.86% vs -1.67%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAATMAJFISCHER
SectorHealthcare
IndustryMedical Equipment & Supplies

Price

MetricAATMAJFISCHER
Live Price₹32.87
Day Change-0.84%
Volume15.46 L
52-Week High₹124.7
52-Week Low₹31.05
Distance from 52W High-73.64%

Valuation

MetricAATMAJFISCHER
Market Cap₹44 Cr₹2,160 Cr
P/E Ratio72.72x
P/B Ratio5.7x
EPS₹0.32₹0.45
Book Value₹22.49₹5.96
Dividend Yield0%0.15%

Growth

MetricAATMAJFISCHER
Revenue Growth (TTM YoY)0%98.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth124.95%11,250.98%
Qtr Profit Growth39.69%208.2%

Profitability & Leverage

MetricAATMAJFISCHER
ROE1.4%-3.08%
ROCE2.86%-1.67%
Net Margin0%6.79%
Operating Margin9.66%-33.66%
Debt to Equity0.41x0.04x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricAATMAJFISCHER
Promoter Holding64.33% 0.57 pp12.31% 0.85 pp
FII Holding0%5.57% 0.09 pp
DII Holding0%1.26% 0.09 pp
Public Holding35.67% 0.57 pp30.09% 0.93 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AATMAJ and FISCHER MEDICAL VENTURE L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.